Subgroup analyses revealed consistent performance across different specimen types and geographic regions.<h4>Conclusion</h4>CDO1 promoter methylation detection in liquid biopsies shows robust diagnostic accuracy for lung cancer, with performance characteristics supporting its potential clinical utility, particularly for older populations who face barriers to conventional screening. This evidence concerns the gene CDO1 and lung cancer.